Recent Updates
Recently added Catalysts
CLPT Positive Sentiment Score: 80/100

ClearPoint Neuro Inc's Innovative Pipeline Products Under Analysis in New 2023 Update

Key Takeaway: ClearPoint Neuro Inc's product pipeline has been extensively documented in a new report that analyzes the company's innovative technologies for treating neuro disorders. The report provides detailed insights into various pipeline products and ongoing clinical trials, enhancing strategic decision-making capabilities for stakeholders. Additionally, ClearPoint has made notable strides, including recent regulatory clearances for their neuro navigation systems, highlighting their commitment to advancing medical technology.

Market Sentiment Analysis

POSITIVE FACTORS

  • ClearPoint Neuro's pipeline includes advanced technologies for treating neurological diseases.
  • The report offers comprehensive actionable intelligence on the company's product portfolio.
  • Recent advancements include additional clearances and installations of innovative systems.

Full Press Release Details

Dublin, Dec. 28, 2023 (GLOBE NEWSWIRE) -- The "ClearPoint Neuro Inc (CLPT) - Product Pipeline Analysis, 2023 Update" company profile has been added to ResearchAndMarkets.com's offering.
ClearPoint Neuro Inc (ClearPoint) is a platform neuro company that enables therapy for neuro disorders with pinpoint accuracy. Its items incorporate the clearpoint framework a careful stage, that empowers the conveyance of treatments to treat neurological infections and issues by giving continuous X-ray direction; the smartFlow cannula an X-ray directed medication conveyance framework.
These frameworks are utilized for carrying out intrusive procedures on the mind and heart. ClearPoint collaborates with different clinical gadget organizations and scholarly establishments for the turn of events and commercialization of its item stages and center advances. It serves doctors and emergency clinics. ClearPoint is headquartered in Solana Beach, California, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company ClearPoint Neuro Inc
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
ClearPoint Neuro Inc Company Overview ClearPoint Neuro Inc Company Snapshot
ClearPoint Neuro Inc Pipeline Products and Ongoing Clinical Trials Overview
ClearPoint Neuro Inc - Pipeline Analysis Overview
ClearPoint Neuro Inc - Key Facts
ClearPoint Neuro Inc - Major Products and Services
ClearPoint Neuro Inc Pipeline Products by Development Stage
ClearPoint Neuro Inc Ongoing Clinical Trials by Trial Status
ClearPoint Neuro Inc Pipeline Products Overview
Brain Computer Interface Navigation Software Brain Computer Interface Navigation Software Product Overview
ClearAblate - Pancreas/Liver
ClearAblate - Pancreas/Liver Product Overview ClearAblate - Pancreatic Cancer
ClearAblate - Pancreatic Cancer Product Overview
ClearPoint - Adjustable Drug Delivery Cannula ClearPoint - Adjustable Drug Delivery Cannula Product Overview
ClearPoint Prism Neuro Laser Therapy System
ClearPoint Prism Neuro Laser Therapy System Product Overview
ClearPoint Prism Neuro Laser Therapy System Clinical Trial
ClearTrace Cardiac Intervention System
ClearTrace Cardiac Intervention System Product Overview
Implantable Neural Electrode Implantable Neural Electrode Product Overview
Microelectric Recording (MER) System Microelectric Recording (MER) System Product Overview
MR Safe Smart Biopsy Needle MR Safe Smart Biopsy Needle Product Overview
MRI-Safe Myocardial Biopsy Forceps MRI-Safe Myocardial Biopsy Forceps Product Overview
Neuro Navigation Device - Alzheimer's Disease Neuro Navigation Device - Alzheimer's Disease Product Overview
Neuro Navigation Device - Insomnia
Neuro Navigation Device - Insomnia Product Overview
Neuro Navigation Device - Parkinson's Disease
Neuro Navigation Device - Parkinson's Disease Product Overview
Neuro Navigation Device - Severe Depression
Neuro Navigation Device - Severe Depression Product Overview
Neuro Navigation Device - Stroke Rehabilitation
Neuro Navigation Device - Stroke Rehabilitation Product Overview
Next-Generation Head Fixation Frames Next-Generation Head Fixation Frames Product Overview
Revolution Robotic-Assisted Navigation System Revolution Robotic-Assisted Navigation System Product Overview
ClearPoint Neuro Inc - Key Competitors ClearPoint Neuro Inc - Key Employees
ClearPoint Neuro Inc - Locations And Subsidiaries
Other Locations & Subsidiaries
Recent Developments ClearPoint Neuro Inc, Recent Developments
Dec 11, 2023: ClearPoint Neuro Receives Additional 510(K) Clearance For ClearPoint Neuro Navigation System
Jun 29, 2023: Abstract From the SUS Study to Be Presented During the ESSFN Congress in Stockholm in September
May 16, 2023: Two Additional Clearpoint Prism Systems Installed in the U.S.
May 10, 2023: ClearPoint Neuro to present investigational research and showcase novel innovations at the 26th American Society of Gene & Cell Therapy Annual Meeting in Los Angeles
May 02, 2023: CLS Announces Enrollment Completion of Initial Phase of CLS-Sponsored Glioblastoma Laser Ablation Study With the Clearpoint Prism Neuro Laser Therapy System at Skane University Hospital
Apr 20, 2023: ClearPoint Neuro to showcase two novel innovations at AANS 2023: ClearPoint Maestro Brain Model and ClearPoint Prism Neuro Laser Therapy System
Apr 18, 2023: ClearPoint Neuro announces agreement with NE Scientific to integrate gene therapy infusion coverage tool into ClearPoint Maestro Brain Model
Dec 12, 2022: ClearPoint Neuro announces first patient enrolled in glioblastoma trial using ClearPoint Prism Neuro Laser Therapy System at Skane University Hospital in Sweden
Oct 17, 2022: Clinical Laserthermia Systems receives SEK 5.5 million order from ClearPoint Neuro
Sep 23, 2022: ClearPoint Neuro announces FDA clearance for ClearPoint Prism neuro laser therapy system
A selection of companies mentioned in this report includes
Varian Medical Systems Inc
For more information about this company profile visit https://www.researchandmarkets.com/r/m9h4f4
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Tags

Frequently Asked Questions

What is ClearPoint Neuro Inc known for?

ClearPoint Neuro Inc specializes in precision therapy for neuro disorders.

Where is ClearPoint Neuro Inc headquartered?

ClearPoint Neuro Inc is based in Solana Beach, California, USA.

What does the ClearPoint platform enable?

The platform allows the delivery of treatments for neurological conditions.

What type of products does ClearPoint develop?

ClearPoint develops neuro navigation systems and drug delivery devices.

What recent achievement did ClearPoint announce?

ClearPoint received additional 510(K) clearance for its Neuro Navigation System.

Last updated: Dec 28, 2023